Skip to main content
Have a personal or library account? Click to login
High-sensitivity C-reactive protein is associated with 24-hour ambulatory blood pressure variability in type 2 diabetes and control subjects Cover

High-sensitivity C-reactive protein is associated with 24-hour ambulatory blood pressure variability in type 2 diabetes and control subjects

Revista Romana de Medicina de Laborator
Volume 24 (2016): Issue 1 (March 2016)
By: ,  ,  ,   and    
Open Access
|Mar 2016
References

References

  1. 1. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132–40. DOI: 10.1016/S0140-6736(09)61717-7
    Open DOISearch in Google Scholar
  2. 2. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke. 2004;35(7):1625–30. DOI: 10.1161/01.STR.0000130422.89335.81
    Open DOISearch in Google Scholar
  3. 3. Hage FG. C-reactive protein and hypertension. J Hum Hypertens. 2014;28(7):410–5. DOI: 10.1038/jhh.2013.111
    Open DOISearch in Google Scholar
  4. 4. Benedek T, Jako B, Suciu Z, Benedek I. Correlations between severity of coronary atherosclerosis and persistent elevation of circulating C-reactive protein levels 30 days after an acute myocardial infarction. Rom Rev Lab Med. 2014;22(1):49–61. DOI: 10.2478/rrlm-2014-0005
    Open DOISearch in Google Scholar
  5. 5. Cernea S, Dobreanu M. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem medica. 2013;23(3):266–80. DOI: 10.11613/BM.2013.033
    Open DOISearch in Google Scholar
  6. 6. Jin C, Lu L, Zhang RY, Zhang Q, Ding FH, Chen QJ, et al. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clin Chim Acta. 2009;408(1-2):45–9. DOI: 10.1016/j.cca.2009.07.003
    Open DOISearch in Google Scholar
  7. 7. Hung M-J, Hsu K-H, Hu W-S, Chang N-C, Hung M-Y. C-reactive protein for predicting prognosis and its gender-specific associations with diabetes mellitus and hypertension in the development of coronary artery spasm. PLoS One. 2013;8(10):e77655. DOI: 10.1371/journal.pone.0077655
    Open DOISearch in Google Scholar
  8. 8. McCormack JP, Allan GM. Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice? PLoS Med. Public Library of Science; 2010;7(2):e1000196.
    Open DOISearch in Google Scholar
  9. 9. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006;166(13):1368–73. DOI: 10.1001/archinte.166.13.1368
    Open DOISearch in Google Scholar
  10. 10. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631–9. DOI: 10.1056/NEJMoa055373
    Open DOISearch in Google Scholar
  11. 11. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood Pressure Variability and Organ Damage in a General Population: Results from the PAMELA Study. Hypertension. 2002;39(2):710–4. DOI: 10.1161/hy0202.104376
    Open DOISearch in Google Scholar
  12. 12. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens. 2013;27(11):663–70. DOI: 10.1038/jhh.2013.45
    Open DOISearch in Google Scholar
  13. 13. Musini VM, Wright JM. Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials. PLoS One. 2009;4(5):e5673. DOI: 10.1371/journal.pone.0005673
    Open DOISearch in Google Scholar
  14. 14. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5(1):93–8. DOI: 10.1097/00004872-198702000-00013
    Open DOISearch in Google Scholar
  15. 15. Kim K-I, Lee J-H, Chang H-J, Cho Y-S, Youn T-J, Chung W-Y, et al. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J. 2008;72(2):293–8. DOI: 10.1253/circj.72.293
    Open DOISearch in Google Scholar
  16. 16. Abramson JL, Lewis C, Murrah NV, Anderson GT, Vaccarino V. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol. 2006;98(5):649–52. DOI: 10.1016/j.amjcard.2006.03.045
    Open DOISearch in Google Scholar
  17. 16. Veerabhadrappa P, Diaz KM, Feairheller DL, Sturgeon KM, Williamson S, Crabbe DL, et al. Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study. J Am Soc Hypertens. 2010;4(4):187–95. DOI: 10.1016/j.jash.2010.04.005
    Open DOISearch in Google Scholar
  18. 18. Pierdomenico SD, Di Nicola M, Esposito AL, Di Mascio R, Ballone E, Lapenna D, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens. 2009;22(8):842–7. DOI: 10.1038/ajh.2009.103
    Open DOISearch in Google Scholar
  19. 19. Tatasciore A, Zimarin M, Rendai G, Zurro M, Soccio M, Prontera C, et al. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res. 2008;31(12):2137–46. DOI: 10.1291/hypres.31.2137
    Open DOISearch in Google Scholar
  20. 20. American Diabetes Association. (2) Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38(1):S8–16.
    Open DOISearch in Google Scholar
  21. 21. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. DOI: 10.1093/eurheartj/eht151
    Open DOISearch in Google Scholar
  22. 22. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716. DOI: 10.1161/01.CIR.0000154900.76284.F6
    Open DOISearch in Google Scholar
  23. 23. American Diabetes Association. (8) Cardiovascular Disease and Risk Management. Diabetes Care. 2015;38(1):S49–51.
    Open DOISearch in Google Scholar
  24. 24. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143–55. DOI: 10.1038/nrcardio.2013.1
    Open DOISearch in Google Scholar
  25. 25. Mena L, Pintos S, Queipo N V, Aizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11. DOI: 10.1097/01.hjh.0000160205.81652.5a
    Open DOISearch in Google Scholar
  26. 26. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11(10):1133–7. DOI: 10.1097/00004872-199310000-00019
    Open DOISearch in Google Scholar
  27. 27. Parati G, Bilo G, Vettorello M, Groppelli A, Maronati A, Tortorici E, et al. Assessment of overall blood pressure variability and its different components. Blood Press Monit. 2003;8(4):155–9. DOI: 10.1097/00126097-200308000-00005
    Open DOISearch in Google Scholar
  28. 28. Pearson TA. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. DOI: 10.1161/01.CIR.0000052939.59093.45
    Open DOISearch in Google Scholar
  29. 29. Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, et al. 2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Clin Investig Arterioscler. 2013;25(2):74-82. DOI: 10.1016/j.arteri.2013.03.002
    Open DOISearch in Google Scholar
  30. 30. Ciobanu DM, Veresiu IA, Bala CG, Roman G, Mircea PA. Benefits of bedtime hypertension medication in type 2 diabetes demonstrated on ambulatory blood pressure monitoring. In: Proceedings of the 49th Annual Scientific Meeting of the European Society for Clinical Investigation. Edited by Dumitrascu DL, Portincasa P. Medimond, Italy. 2015:107–12.
    Search in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2016-0013 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English
Page range: 65 - 74
Submitted on: Oct 12, 2015
Accepted on: Feb 16, 2016
Published on: Mar 19, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
high-sensitivity C-reactive protein,
diabetes mellitus,
blood pressure variability,
24-hour ambulatory blood pressure monitoring
Related subjects:
Life sciences,
Molecular biology

© 2016 Dana Mihaela Ciobanu, Cornelia Gabriela Bala, Ioan Andrei Veresiu, Petru Adrian Mircea, Gabriela Roman, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 24 (2016): Issue 1 (March 2016)
Previous article
Next article